{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:57:11Z","timestamp":1781639831077,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current efforts of increasing diagnosis of primary aldosteronism (PA), a potentially curable but under-diagnosed form of hypertension, have been limited to primary care and specialist clinics, leaving out additional opportunities within healthcare. This study estimated hypertension and PA diagnosis rates during hospital admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Public hospital admissions in Victoria, Australia, between 2007\/8 and 2018\/19 from patients aged\u2009\u2265\u200915years were retrospectively analysed to estimate rates of hypertension as principal diagnosis and PA as principal and secondary diagnosis to hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 27,749,684 admissions identified in the period, with 53.2% females and 68.2% aged\u2009\u2265\u200950years. Nine in 10,000 had a principal diagnosis of hypertension and 51 hypertensive patients also had PA (0.21%, 95% confidence interval 0.15%-0.26%). Principal diagnosis of PA occurred in 0.31\/10,000 admissions, with higher diagnosis among males than females (0.34\/10,000 vs. 0.29\/10,000 admissions; p-value\u2009=\u20090.019) and highest amongst patients aged 50-59years (0.63\/10,000 admissions) compared with 0.23\/10,000 and 0.07\/10,000 amongst those aged\u2009&lt;\u200940years and \u2265\u200970years, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Under 1% of patients admitted into hospital had a principal diagnosis of hypertension. Although this number is small, the presentations offer an opportunity for clinicians to test patients for PA. The proportion of hypertensive patients diagnosed with PA during admission was lower than the estimated 15% prevalence among hypertensive individuals, however this also highlights that PA diagnosis can occur in this setting. Future research should explore barriers and facilitators to PA diagnosis when patients are admitted to hospital with hypertension, and develop strategies to support timely diagnosis in this setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-026-04562-2","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:21:32Z","timestamp":1773066092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension and primary aldosteronism diagnosis in hospitalized patients: an observation from public hospitals in Victoria, Australia"],"prefix":"10.1007","volume":"91","author":[{"given":"Stella May","family":"Gwini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"7","key":"4562_CR1","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC K\u00e4yser","year":"2016","unstructured":"S.C. K\u00e4yser, T. Dekkers, H.J. Groenewoud et al., Study heterogeneity and Estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J. Clin. Endocrinol. Metabolism. 101(7), 2826\u20132835 (2016)","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"4","key":"4562_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","volume":"75","author":"J Burrello","year":"2020","unstructured":"J. Burrello, S. Monticone, I. Losano et al., Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension. 75(4), 1025\u20131033 (2020). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14063","journal-title":"Hypertension"},{"issue":"6","key":"4562_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/eje-17-0978","volume":"178","author":"DA Heinrich","year":"2018","unstructured":"D.A. Heinrich, C. Adolf, L.C. Rump et al., Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms. Eur. J. Endocrinol. 178(6), 605\u2013611 (2018). https:\/\/doi.org\/10.1530\/eje-17-0978","journal-title":"Eur. J. Endocrinol."},{"key":"4562_CR4","doi-asserted-by":"publisher","first-page":"574151","DOI":"10.3389\/fendo.2020.574151","volume":"11","author":"S Shi","year":"2020","unstructured":"S. Shi, C. Lu, H. Tian, Y. Ren, T. Chen, Primary aldosteronism and bone metabolism: A systematic review and Meta-Analysis. Front. Endocrinol. 11, 574151 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.574151","journal-title":"Front. Endocrinol."},{"issue":"5","key":"4562_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/eje-17-0417","volume":"177","author":"AS Salcuni","year":"2017","unstructured":"A.S. Salcuni, V. Carnevale, C. Battista et al., Primary aldosteronism as a cause of secondary osteoporosis. European J. Endocrinology Nov. 177(5), 431\u2013437 (2017). https:\/\/doi.org\/10.1530\/eje-17-0417","journal-title":"European J. Endocrinology Nov"},{"issue":"1","key":"4562_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti et al., Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6(1), 41\u201350 (2018)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"4562_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","volume":"38","author":"S Monticone","year":"2020","unstructured":"S. Monticone, E. Sconfienza, F. D\u2019Ascenzo et al., Renal damage in primary aldosteronism: a systematic review and meta-analysis. J. Hypertens. 38(1), 3\u201312 (2020)","journal-title":"J. Hypertens."},{"issue":"4","key":"4562_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","volume":"71","author":"GP Rossi","year":"2018","unstructured":"G.P. Rossi, G. Maiolino, A. Flego et al., Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term. Hypertension. 71(4), 585\u2013591 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10596","journal-title":"Hypertension"},{"issue":"8","key":"4562_CR9","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/hjh.0000000000001361","volume":"35","author":"V-C Wu","year":"2017","unstructured":"V.-C. Wu, S.-C.J. Chueh, L. Chen et al., Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years. J. Hypertens. 35(8), 1698\u20131708 (2017). https:\/\/doi.org\/10.1097\/hjh.0000000000001361","journal-title":"J. Hypertens."},{"issue":"3","key":"4562_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","volume":"72","author":"GL Hundemer","year":"2018","unstructured":"G.L. Hundemer, G.C. Curhan, N. Yozamp, M. Wang, A. Vaidya, Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension. 72(3), 658\u2013666 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11568","journal-title":"Hypertension"},{"issue":"9","key":"4562_CR11","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","volume":"110","author":"GK Adler","year":"2025","unstructured":"G.K. Adler, M. Stowasser, R.R. Correa et al., Primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metabolism. 110(9), 2453\u20132495 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgaf284","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4562_CR12","doi-asserted-by":"publisher","unstructured":"M. Funes Hernandez, V. Bhalla, Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection. American Journal of Kidney Diseases. 2023\/09\/01\/ 2023;82(3):333\u2013346. https:\/\/doi.org\/10.1053\/j.ajkd.2023.01.447","DOI":"10.1053\/j.ajkd.2023.01.447"},{"issue":"2","key":"4562_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5694\/mja17.00783","volume":"16","author":"J Yang","year":"2018","unstructured":"J. Yang, P.J. Fuller, M. Stowasser, Is it time to screen all patients with hypertension for primary aldosteronism? Medical J. Australia Jul. 16(2), 57\u201359 (2018). https:\/\/doi.org\/10.5694\/mja17.00783","journal-title":"Medical J. Australia Jul"},{"issue":"7","key":"4562_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41371-020-0336-2","volume":"07","author":"R Libianto","year":"2020","unstructured":"R. Libianto, P.J. Fuller, M.J. Young, J. Yang, Primary aldosteronism is a public health issue: challenges and opportunities. J. Hum. Hypertens. 07(7), 478\u2013486 (2020). https:\/\/doi.org\/10.1038\/s41371-020-0336-2. \/01 2020","journal-title":"J. Hum. Hypertens."},{"issue":"8","key":"4562_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5694\/mja2.51438","volume":"216","author":"R Libianto","year":"2022","unstructured":"R. Libianto, G.M. Russell, M. Stowasser et al., Detecting primary aldosteronism in Australian primary care: a prospective study. Med. J. Aust. 216(8), 408\u2013412 (2022)","journal-title":"Med. J. Aust."},{"issue":"1","key":"4562_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"J.M. Brown, M. Siddiqui, D.A. Calhoun et al., The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann. Intern. Med. 173(1), 10\u201320 (2020)","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"4562_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","volume":"38","author":"M Parasiliti-Caprino","year":"2020","unstructured":"M. Parasiliti-Caprino, C. Lopez, N. Prencipe et al., Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. J. Hypertens. 38(9), 1841\u20131848 (2020)","journal-title":"J. Hypertens."},{"issue":"3","key":"4562_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1524-6175.2003.02464.x","volume":"5","author":"WC Cushman","year":"2003","unstructured":"W.C. Cushman, The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression. J. Clin. Hypertens. 5(3), 14\u201322 (2003). https:\/\/doi.org\/10.1111\/j.1524-6175.2003.02464.x","journal-title":"J. Clin. Hypertens."},{"key":"4562_CR19","unstructured":"WHO. Hypertension. World Health Organisation, Accessed 31\/08\/2023, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension#:~:text=Less%20than%20half%20of%20adults,cause%20of%20premature%20death%20worldwide"},{"issue":"10199","key":"4562_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","volume":"394","author":"B Zhou","year":"2019","unstructured":"B. Zhou, G. Danaei, G.A. Stevens et al., Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 394(10199), 639\u2013651 (2019)","journal-title":"Lancet"},{"issue":"6","key":"4562_CR21","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1097\/hjh.0000000000002785","volume":"39","author":"J Roseleur","year":"2021","unstructured":"J. Roseleur, D.A. Gonzalez-Chica, C.O. Bernardo, B.P. Geisler, J. Karnon, N.P. Stocks, Blood pressure control in Australian general practice: analysis using general practice records of 1.2 million patients from the medicineinsight database. J. Hypertens. 39(6), 1134\u20131142 (2021). https:\/\/doi.org\/10.1097\/hjh.0000000000002785","journal-title":"J. Hypertens."},{"issue":"12","key":"4562_CR22","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1097\/hjh.0000000000002192","volume":"37","author":"AS Wu","year":"2019","unstructured":"A.S. Wu, H. Dodhia, D. Whitney, M. Ashworth, Is the rule of halves still relevant today? A cross-sectional analysis of hypertension detection, treatment and control in an urban community. J. Hypertens. 37(12), 2470\u20132480 (2019). https:\/\/doi.org\/10.1097\/hjh.0000000000002192","journal-title":"J. Hypertens."},{"issue":"1","key":"4562_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12872-020-01407-2","volume":"2020\/03\/13","author":"J Petersen","year":"2020","unstructured":"J. Petersen, S. Malyutina, A. Ryabikov et al., Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40\u201369 year olds. BMC Cardiovasc. Disord. 2020\/03\/13(1), 135 (2020). https:\/\/doi.org\/10.1186\/s12872-020-01407-2","journal-title":"BMC Cardiovasc. Disord."},{"key":"4562_CR24","doi-asserted-by":"crossref","unstructured":"A.E. Schutte, R. Webster, G. Jennings, M.P. Schlaich, Uncontrolled blood pressure in australia: a call to action. Med. J. Aust. 2022;216(2)","DOI":"10.5694\/mja2.51350"},{"issue":"7","key":"4562_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/jhh.2012.62","volume":"2013\/07\/01","author":"SL Appleton","year":"2013","unstructured":"S.L. Appleton, C. Neo, C.L. Hill, K.A. Douglas, R.J. Adams, Untreated hypertension: prevalence and patient factors and beliefs associated with under-treatment in a population sample. J. Hum. Hypertens. 2013\/07\/01(7), 453\u2013462 (2013). https:\/\/doi.org\/10.1038\/jhh.2012.62","journal-title":"J. Hum. Hypertens."},{"issue":"10060","key":"4562_CR26","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","volume":"388","author":"MH Olsen","year":"2016","unstructured":"M.H. Olsen, S.Y. Angell, S. Asma et al., A call to action and a lifecourse strategy to address the global burden of Raised blood pressure on current and future generations: the lancet commission on hypertension. Lancet. 388(10060), 2665\u20132712 (2016)","journal-title":"Lancet"},{"issue":"3","key":"4562_CR27","doi-asserted-by":"publisher","first-page":"eAO4283","DOI":"10.1590\/s1679-45082018ao4283","volume":"21","author":"RCO Dantas","year":"2018","unstructured":"R.C.O. Dantas, J. Silva, D.C.O. Dantas, \u00c2.G. Roncalli, Factors associated with hospital admissions due to hypertension. Einstein (Sao Paulo). Sep 21(3), eAO4283 (2018). https:\/\/doi.org\/10.1590\/s1679-45082018ao4283","journal-title":"Einstein (Sao Paulo)"},{"issue":"7","key":"4562_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jhm.804","volume":"6","author":"RN Axon","year":"2011","unstructured":"R.N. Axon, L. Cousineau, B.M. Egan, Prevalence and management of hypertension in the inpatient setting: a systematic review. J. Hosp. Med. 6(7), 417\u2013422 (2011)","journal-title":"J. Hosp. Med."},{"key":"4562_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.archger.2009.09.021","volume":"49","author":"V Giantin","year":"2009","unstructured":"V. Giantin, A. Franchin, E.D. Toffanello et al., Masked and white-coat hypertension in two cohorts of elderly subjects, ambulatory and hospitalized patients. Arch. Gerontol. Geriatr. 49, 125\u2013128 (2009)","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"3","key":"4562_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/jch.14431","volume":"24","author":"L Ghazi","year":"2022","unstructured":"L. Ghazi, F. Li, X. Chen et al., Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment. J. Clin. Hypertens. 24(3), 339\u2013349 (2022). https:\/\/doi.org\/10.1111\/jch.14431","journal-title":"J. Clin. Hypertens."},{"issue":"3","key":"4562_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/j.ajkd.2023.01.447","volume":"82","author":"MF Hernandez","year":"2023","unstructured":"M.F. Hernandez, V. Bhalla, Underdiagnosis of primary aldosteronism: a review of screening and detection. Am. J. Kidney Dis. 82(3), 333\u2013346 (2023)","journal-title":"Am. J. Kidney Dis."},{"key":"4562_CR32","doi-asserted-by":"crossref","unstructured":"J.B. Cohen, D.L. Cohen, D.S. Herman, J.T. Leppert, J.B. Byrd, V. Bhalla, Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. Veterans. Ann. Intern. Med. 174(3), 289\u2013297 (2021). 10.7326\/m20-4873%m","DOI":"10.7326\/M20-4873"},{"key":"4562_CR33","doi-asserted-by":"publisher","first-page":"665912","DOI":"10.3389\/fendo.2021.665912","volume":"12","author":"C Wang","year":"2021","unstructured":"C. Wang, H. Jing, Z. Sun et al., A bibliometric analysis of primary aldosteronism research from 2000 to 2020. Front. Endocrinol. 12, 665912 (2021)","journal-title":"Front. Endocrinol."},{"issue":"8","key":"4562_CR34","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/imj.14879","volume":"51","author":"YY Lim","year":"2021","unstructured":"Y.Y. Lim, R. Libianto, J. Shen, M.J. Young, P.J. Fuller, J. Yang, Impact of victoria\u2019s first dedicated endocrine hypertension service on the pattern of primary aldosteronism diagnoses. Intern. Med. J. 51(8), 1255\u20131261 (2021)","journal-title":"Intern. Med. J."},{"issue":"10","key":"4562_CR35","doi-asserted-by":"publisher","first-page":"712","DOI":"10.31128\/AJGP-05-18-4587","volume":"47","author":"YY Lim","year":"2018","unstructured":"Y.Y. Lim, J. Shen, P.J. Fuller, J. Yang, Current pattern of primary aldosteronism diagnosis: delayed and complicated. Australian J. Gen. Pract. 47(10), 712\u2013718 (2018)","journal-title":"Australian J. Gen. Pract."},{"key":"4562_CR36","doi-asserted-by":"publisher","unstructured":"P.C. Austin, P.A. Daly, J.V. Tu, A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. American Heart Journal. 2002\/08\/01\/ 2002;144(2):290\u2013296. https:\/\/doi.org\/10.1067\/mhj.2002.123839","DOI":"10.1067\/mhj.2002.123839"},{"issue":"5","key":"4562_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1467-842X.1997.tb01738.x","volume":"21","author":"CR MacIntyre","year":"1997","unstructured":"C.R. MacIntyre, M.J. Ackland, E.J. Chandraraj, J.E. Pilla, Accuracy of ICD\u20139\u2013CM codes in hospital morbidity data, victoria: implications for public health research. Aust. N. Z. J. Public Health. 21(5), 477\u2013482 (1997)","journal-title":"Aust. N. Z. J. Public Health"},{"key":"4562_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.70035","author":"MC Shih","year":"2025","unstructured":"M.C. Shih, T.R. Lavorgna, P. Dogra, C.N. Hirner, K. Payne, Things we do for no reason: failing to consider primary aldosteronism in the initial evaluation of hypertension, hypertensive urgency, and hypertensive emergency. J. Hosp. Med. (2025). https:\/\/doi.org\/10.1002\/jhm.70035","journal-title":"J. Hosp. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04562-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04562-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04562-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:39:22Z","timestamp":1781638762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04562-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4562"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04562-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"97"}}